Analysis of repeated biopsy results within 1 year after a noncancer diagnosis

Urology

Volumn 55, Issue 4, 2000, Pages 553-558

  O'Dowd, Gerard J ^a   Miller, M Craig ^a   Orozco, Roberto ^a   Veltri, Robert W ^b  

^a UroCor Incorporated   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER DIAGNOSIS; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; REGRESSION ANALYSIS; RISK ASSESSMENT;

AGED; BIOPSY; CELL TRANSFORMATION, NEOPLASTIC; FOLLOW-UP STUDIES; HUMANS; LIKELIHOOD FUNCTIONS; MALE; MIDDLE AGED; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; REOPERATION; RETROSPECTIVE STUDIES;

EID: 0034017586     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(00)00447-7     Document Type: Article

References (26)

1. Catalona W.J., Richie J.P., Ahamann F.R., et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer results of a multicenter clinical trial of 6,630 men . J Urol. 151:1994;1283-1290.
2. Brawer M.K., Chetner M.P., Beatie J., et al. Screening for prostatic carcinoma with prostate specific antigen. J Urol. 147:1992;841-845.
3. Jacobson S.J., Datusic D.K., Bergstralh E.J., et al. Incidence of prostate cancer diagnosis in years before and after serum prostate-specific antigen testing. JAMA. 274:1995;1445-1449.
4. Orozco R., O'Dowd G.J., Kunnel B., et al. Observations on pathology trends in 62,537 prostate biopsies obtained from urology private practices in the United States. Urology. 51:1998;186-195.
5. Hodge K.K., McNeal J.E., Terris M.K., et al. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol. 142:1989;71-74.
6. Chen M.E., Troncoso P., Johnston D.A., et al. Optimization of prostate biopsy strategy using computer based analysis. J Urol. 158:1997;2168-2175.
7. Norberg M., Egevad L., Holmberg L., et al. The sextant protocol for ultrasound guided core biopsies of the prostate underestimates the presence of cancer. Urology. 50:1997;562-566.
8. Keetch D.W., Catalona W.J., Smith D.S. Serial prostatic biopsies in men with persistently elevated serum prostate-specific antigen values. J Urol. 151:1994;1571-1574.
9. Ellis W.J., Brawer M.K. Repeat prostate needle biopsy who needs it? J Urol. 153:1995;1496-1498.
10. Fleshner N.E., O'Sullivan M., Fair W.R. Prevalence and predictors of a positive repeat transrectal ultrasound guided needle biopsy of the prostate. J Urol. 158:1997;505-509.
11. Roehrborn C.R., Pickens G.J., Sanders J. Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by histopathologic diagnoses and prostate-specific antigen level. Urology. 47:1996;347-352.
12. Prestigiacomo A.F., Lilja H., Pettersson K., et al. A comparison of the free fraction of serum prostate specific antigen in men with benign and cancerous prostates the best case scenario . J Urol. 156:1996;350-354.
13. Carter H.B., Partin A.W., Luderer A.A., et al. Percentage of free prostate-specific antigen in sera predicts aggressiveness of prostate cancer a decade before diagnosis. Urology. 49:1997;379-384.
14. Partin A.W., Catalona W.J., Southwick P.C., et al. Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection influence of total PSA, prostate volume and age . Urology. 48:(suppl 6A):1996;55-61.
15. Veltri R.W., Miller M.C. Free/total PSA ratios improve differentiation of benign and malignant disease of the prostate critical analysis of two different test populations . Urology. 53:1999;736-745.
16. Letran J.L., Blase A.B., Loberiza F.R., et al. Repeat ultrasound guided prostate needle biopsy use of free to total PSA ratio in predicting prostatic carcinoma . J Urol. 160:1998;426-429.
17. Brawer M.K., Bigler S.A., Sohlberg O.E., et al. Significance of prostatic intraepithelial neoplasia on prostate needle biopsy. Urology. 38:1991;103-107.
18. Wills M.L., Hamper U.M., Partin A.W., et al. Incidence of high-grade prostatic intraepithelial neoplasia in sextant needle biopsy specimens. Urology. 49:1997;367-373.
19. Iczkowski K.A., Bassler T.J., Schwob V.S., et al. Diagnosis of "suspicious for malignancy" in prostate biopsies predictive value for cancer . Urology. 51:1998;749-758.
20. Davidson D., Bostwick D.G., Qian J., et al. Prostatic intraepithelial neoplasia is a risk factor for adenocarcinoma predictive accuracy in needle biopsies . J Urol. 154:1995;1295-1299.
21. Qian J., Jenkins R.B., Bostwick D.G. Genetic and chromosomal alterations in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Eur Urol. 35:1999;479-483.
22. Rietbergen J.B., Kruger A.E., Hoedemaeker R.F., et al. Repeat screening for prostate cancer after 1-year follow up in 984 biopsied men clinical and pathological features of detected cancer . J Urol. 160:1998;2121-2125.
23. Vashi A.R., Wojno K.J., Gillespie B., et al. A model for the number of cores per prostate biopsy based on patient age and prostate gland volume. J Urol. 159:1998;920-924.
24. Allen E.A., Kahane H., Epstein J.I. Repeat biopsy strategies for men with atypical diagnoses on initial prostate needle biopsy. Urology. 52:1999;803-807.
25. Veltri R.W., Miller M.C., Zhao G., et al. Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer. Urology. 53:1999;139-147.
26. Veltri R.W., O'Dowd G.J., Orozco R., et al. The role of biopsy pathology, quantitative nuclear morphometry, and biomarkers in the pre-op prediction of prostate cancer staging and prognosis. Semin Urol Oncol. 16:1998;106-117.